Global Bioactive Wound Management Market to Reach $2.7 Billion by 2027 – GlobeNewswire

| Source: ReportLinker ReportLinker
Lyon, FRANCE
New York, Oct. 13, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Bioactive Wound Management Industry” – https://www.reportlinker.com/p06044437/?utm_source=GNW

Online interactive peer-to-peer collaborative bespoke updates

Access to our digital archives and MarketGlass Research Platform

Complimentary updates for one yearGlobal Bioactive Wound Management Market to Reach $2.7 Billion by 2027
– In the changed post COVID-19 business landscape, the global market for Bioactive Wound Management estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 7.8% over the analysis period 2020-2027. Alginates, one of the segments analyzed in the report, is projected to record a 6.8% CAGR and reach US$826.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Collagen-Based Dressings segment is readjusted to a revised 9.1% CAGR for the next 7-year period.
– The U.S. Market is Estimated at $619.2 Million, While China is Forecast to Grow at 9.8% CAGR
– The Bioactive Wound Management market in the U.S. is estimated at US$619.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$230.1 Million by the year 2027 trailing a CAGR of 9.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 6.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.Antimicrobial Dressings Segment to Record 6.3% CAGR
– In the global Antimicrobial Dressings segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$248.1 Million in the year 2020 will reach a projected size of US$377.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 90 Featured)
3M Company
B. Braun Melsungen AG
Coloplast A/S
ConvaTec Group plc
Covalon Technologies Ltd.
DermaRite Industries, LLC
ETS Wound Care, LLC
Hartmann USA, Inc.
Hollister Incorporated
Integra LifeSciences Holdings Corporation
Johnson & Johnson Services, Inc.
Medtronic PLC
MiMedx Group
Mölnlycke Health Care AB
Organogenesis Inc.
Smith & Nephew PLC

Read the full report: https://www.reportlinker.com/p06044437/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Review of
the World Economy in 2021
World Economic Growth Projections (Real GDP, Annual % Change)
for 2020 through 2022
COVID-19-Led Wound Management Crisis & Patient Suffering Create
Need for Effective Interventions
Dwindling Revenues for Wound Care Practices
Telemedicine, Remote Patient Monitoring Takes Center Stage
Influencer Market Insights
World Market Trajectories
Bioactive Wound Management – Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Wounds & Wound Management: A Prelude
Bioactive Wound Management: A Prelude
Outlook
Healthcare Burden of Chronic Wounds and the Need for Effective
Wound Management Products
Prevalence and Incidence of Wounds – Select Statistics
Global Prevalence of Wounds by Type (in Millions)
Global Wound Care Market: Percentage Breakdown of Spending by
Wound Type
Healing Time by Type of Wound (in Days)
Chronic Wounds: Select Statistics
Reduced Economic Cost of Wound Care Triggers Transition to
Advanced Products
Breakdown of Costs Associated with Wound Care
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Effective Burn Wound Management with Bioactive Dressings
Uptrend in Surgical Care Augurs Well for Market Growth
Global Surgical Procedure Volume by Procedure Type
Rise in Prevalence of Pressure Ulcers and the Growing Focus on
Treatment Solutions
Pressure Ulcer Occurrence Rate Based on the Length of Surgery
Understanding the Wound: A Widening Area of Interest
Smart? Dressings Set the Road to Futuristic Wound Care
Startups Enter the Fray
Growing Focus on Reducing Hospital Stays Lends Traction
Technological Advancements Remain Buoyant
Conductive Bio-material Wound Dressings Beneficial for Wound
Healing
Combination Dressings Emerge as a Key Trend
Cellulose-based Dressings Exude Immense Potential for Chronic
Wound Management
3D-Printed Stem Cells & Lasers to Kill Bacteria
New Bioactive Wound Dressings
Chitin, Chitosan and Derivatives
Bioactive Glasses Show Promising Wound Healing Outcomes
Rising Incidence of Diabetes and DFUs to Propel Market Growth
World Diabetes and Population Statistics (2019, 2030 & 2045)
Global Diabetes Mellitus Population Breakdown by Geographic
Region: 2019, 2030 and 2045
World Diabetes Prevalence (2000 – 2019)
COVID-19 Crisis & Restrictions Upend Care for Diabetic Foot
Disease Patients
Growing Acceptance of Moist Wound Environment Spurs Demand for
Moist Wound Dressings
Alginate Dressings Dominate the Market
Antimicrobial Dressings Find Application for Healing Wounds
with High Bacterial Load
Multi-Drug Resistant Bacteria: A Pressing Concern
Tissue Engineering in Wound Care
Bioengineered Skin Substitutes
Collagen Dressings in Advanced Wound Care
MACRO GROWTH DRIVERS
Impact of Healthcare Expenditure on Market Growth
World Healthcare Expenditure (In US$ Billion) for the Years
2017-2023
Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and
2050
Expanding Aging Population Spurs Demand
Global Population Statistics for the 65+ Age Group in Million
by Geographic Region for the Years 2019, 2025, 2035 and 2050
Growing Obesity Levels Fuel Demand
Global Obesity Epidemic: Percentage of Overweight, Obese, and
Severely Obese Adults for 2014 & 2025

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Bioactive Wound Management by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Bioactive Wound Management
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 3: World 11-Year Perspective for Bioactive Wound
Management by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2016, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Alginates by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 5: World Historic Review for Alginates by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2016 through 2019 and % CAGR

Table 6: World 11-Year Perspective for Alginates by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2016, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Collagen-Based Dressings by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Collagen-Based Dressings by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 9: World 11-Year Perspective for Collagen-Based Dressings
by Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Antimicrobial Dressings by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Antimicrobial Dressings by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 12: World 11-Year Perspective for Antimicrobial Dressings
by Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Bioengineered Skin Substitutes by Geographic Region – USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Bioengineered Skin
Substitutes by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2016 through
2019 and % CAGR

Table 15: World 11-Year Perspective for Bioengineered Skin
Substitutes by Geographic Region – Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2016, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Hydrocolloids by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Hydrocolloids by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2016 through 2019 and % CAGR

Table 18: World 11-Year Perspective for Hydrocolloids by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for Burn
Wounds by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 20: World Historic Review for Burn Wounds by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2016 through 2019 and % CAGR

Table 21: World 11-Year Perspective for Burn Wounds by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Surgical Wounds by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Surgical Wounds by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 24: World 11-Year Perspective for Surgical Wounds by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Diabetic Foot Ulcers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Diabetic Foot Ulcers by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 27: World 11-Year Perspective for Diabetic Foot Ulcers by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Venous Leg Ulcers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 29: World Historic Review for Venous Leg Ulcers by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 30: World 11-Year Perspective for Venous Leg Ulcers by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 31: World Recent Past, Current & Future Analysis for
Pressure Ulcers by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Pressure Ulcers by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 33: World 11-Year Perspective for Pressure Ulcers by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 34: World Recent Past, Current & Future Analysis for
Hospitals & Clinics by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 35: World Historic Review for Hospitals & Clinics by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 36: World 11-Year Perspective for Hospitals & Clinics by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 37: World Recent Past, Current & Future Analysis for
Ambulatory Surgical Centers by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 38: World Historic Review for Ambulatory Surgical Centers
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 39: World 11-Year Perspective for Ambulatory Surgical
Centers by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2016, 2021 & 2027

Table 40: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 41: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019
and % CAGR

Table 42: World 11-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Bioactive Wound Management Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in the United States for 2022
(E)
Table 43: USA Recent Past, Current & Future Analysis for
Bioactive Wound Management by Product – Alginates,
Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: USA Historic Review for Bioactive Wound Management by
Product – Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 45: USA 11-Year Perspective for Bioactive Wound
Management by Product – Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 46: USA Recent Past, Current & Future Analysis for
Bioactive Wound Management by Application – Burn Wounds,
Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and
Pressure Ulcers – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 47: USA Historic Review for Bioactive Wound Management by
Application – Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 48: USA 11-Year Perspective for Bioactive Wound
Management by Application – Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 49: USA Recent Past, Current & Future Analysis for
Bioactive Wound Management by End-Use – Hospitals & Clinics,
Ambulatory Surgical Centers and Other End-Uses – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 50: USA Historic Review for Bioactive Wound Management by
End-Use – Hospitals & Clinics, Ambulatory Surgical Centers and
Other End-Uses Markets – Independent Analysis of Annual Sales
in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 51: USA 11-Year Perspective for Bioactive Wound
Management by End-Use – Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

CANADA
Table 52: Canada Recent Past, Current & Future Analysis for
Bioactive Wound Management by Product – Alginates,
Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Canada Historic Review for Bioactive Wound Management
by Product – Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 54: Canada 11-Year Perspective for Bioactive Wound
Management by Product – Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 55: Canada Recent Past, Current & Future Analysis for
Bioactive Wound Management by Application – Burn Wounds,
Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and
Pressure Ulcers – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Canada Historic Review for Bioactive Wound Management
by Application – Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 57: Canada 11-Year Perspective for Bioactive Wound
Management by Application – Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 58: Canada Recent Past, Current & Future Analysis for
Bioactive Wound Management by End-Use – Hospitals & Clinics,
Ambulatory Surgical Centers and Other End-Uses – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 59: Canada Historic Review for Bioactive Wound Management
by End-Use – Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 60: Canada 11-Year Perspective for Bioactive Wound
Management by End-Use – Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

JAPAN
Bioactive Wound Management Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in Japan for 2022 (E)
Table 61: Japan Recent Past, Current & Future Analysis for
Bioactive Wound Management by Product – Alginates,
Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: Japan Historic Review for Bioactive Wound Management
by Product – Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 63: Japan 11-Year Perspective for Bioactive Wound
Management by Product – Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 64: Japan Recent Past, Current & Future Analysis for
Bioactive Wound Management by Application – Burn Wounds,
Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and
Pressure Ulcers – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Japan Historic Review for Bioactive Wound Management
by Application – Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 66: Japan 11-Year Perspective for Bioactive Wound
Management by Application – Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 67: Japan Recent Past, Current & Future Analysis for
Bioactive Wound Management by End-Use – Hospitals & Clinics,
Ambulatory Surgical Centers and Other End-Uses – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 68: Japan Historic Review for Bioactive Wound Management
by End-Use – Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 69: Japan 11-Year Perspective for Bioactive Wound
Management by End-Use – Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

CHINA
Bioactive Wound Management Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in China for 2022 (E)
Table 70: China Recent Past, Current & Future Analysis for
Bioactive Wound Management by Product – Alginates,
Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 71: China Historic Review for Bioactive Wound Management
by Product – Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 72: China 11-Year Perspective for Bioactive Wound
Management by Product – Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 73: China Recent Past, Current & Future Analysis for
Bioactive Wound Management by Application – Burn Wounds,
Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and
Pressure Ulcers – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 74: China Historic Review for Bioactive Wound Management
by Application – Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 75: China 11-Year Perspective for Bioactive Wound
Management by Application – Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 76: China Recent Past, Current & Future Analysis for
Bioactive Wound Management by End-Use – Hospitals & Clinics,
Ambulatory Surgical Centers and Other End-Uses – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 77: China Historic Review for Bioactive Wound Management
by End-Use – Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 78: China 11-Year Perspective for Bioactive Wound
Management by End-Use – Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

EUROPE
Bioactive Wound Management Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in Europe for 2022 (E)
Table 79: Europe Recent Past, Current & Future Analysis for
Bioactive Wound Management by Geographic Region – France,
Germany, Italy, UK and Rest of Europe Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 80: Europe Historic Review for Bioactive Wound Management
by Geographic Region – France, Germany, Italy, UK and Rest of
Europe Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2016 through 2019 and % CAGR

Table 81: Europe 11-Year Perspective for Bioactive Wound
Management by Geographic Region – Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2016, 2021 & 2027

Table 82: Europe Recent Past, Current & Future Analysis for
Bioactive Wound Management by Product – Alginates,
Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: Europe Historic Review for Bioactive Wound Management
by Product – Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 84: Europe 11-Year Perspective for Bioactive Wound
Management by Product – Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 85: Europe Recent Past, Current & Future Analysis for
Bioactive Wound Management by Application – Burn Wounds,
Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and
Pressure Ulcers – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: Europe Historic Review for Bioactive Wound Management
by Application – Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 87: Europe 11-Year Perspective for Bioactive Wound
Management by Application – Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 88: Europe Recent Past, Current & Future Analysis for
Bioactive Wound Management by End-Use – Hospitals & Clinics,
Ambulatory Surgical Centers and Other End-Uses – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 89: Europe Historic Review for Bioactive Wound Management
by End-Use – Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 90: Europe 11-Year Perspective for Bioactive Wound
Management by End-Use – Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

FRANCE
Bioactive Wound Management Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in France for 2022 (E)
Table 91: France Recent Past, Current & Future Analysis for
Bioactive Wound Management by Product – Alginates,
Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: France Historic Review for Bioactive Wound Management
by Product – Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 93: France 11-Year Perspective for Bioactive Wound
Management by Product – Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 94: France Recent Past, Current & Future Analysis for
Bioactive Wound Management by Application – Burn Wounds,
Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and
Pressure Ulcers – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 95: France Historic Review for Bioactive Wound Management
by Application – Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 96: France 11-Year Perspective for Bioactive Wound
Management by Application – Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 97: France Recent Past, Current & Future Analysis for
Bioactive Wound Management by End-Use – Hospitals & Clinics,
Ambulatory Surgical Centers and Other End-Uses – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 98: France Historic Review for Bioactive Wound Management
by End-Use – Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets – Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 99: France 11-Year Perspective for Bioactive Wound
Management by End-Use – Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

GERMANY
Bioactive Wound Management Market Presence – Strong/Active/
Niche/Trivial – Key Competitors in Germany for 2022 (E)
Table 100: Germany Recent Past, Current & Future Analysis for
Bioactive Wound Management by Product – Alginates,
Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 101: Germany Historic Review for Bioactive Wound
Management by Product – Alginates, Collagen-Based Dressings,
Antimicrobial Dressings, Bioengineered Skin Substitutes and
Hydrocolloids Markets – Independent Analysis of Annual Sales in
US$ Thousand for Years 2016 through 2019 and % CAGR

Table 102: Germany 11-Year Perspective for Bioactive Wound
Management by Product – Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 103: Germany Recent Past, Current & Future Analysis for
Bioactive Wound Management by Application – Burn Wounds,
Surgical Wounds, Diabetic Foot Ulcers, Venous Leg Ulcers and
Pressure Ulcers – Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 104: Germany Historic Review for Bioactive Wound
Management by Application – Burn Wounds, Surgical Wounds,
Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 105: Germany 11-Year Perspective for Bioactive Wound
Management by Application – Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 106: Germany Recent Past, Current & Future Analysis for
Bioactive Wound Management by End-Use – Hospitals & Clinics,
Ambulatory Surgical Centers and Other End-Uses – Independent

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06044437/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

source